#29 – Endpoints News: Predictions for Biotech in 2024 and Beyond | John Carroll

Ventured Growth with Hercules Capital

内容由Hercules Capital提供。所有播客内容（包括剧集、图形和播客描述）均由 Hercules Capital 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

10M ago 46:00

MP3•单集首页

In the aftermath of the 2020 biotech surge and its subsequent contraction in 2022, the biotech industry has been characterized by significant volatility. There were 21 biotechnology IPOs in 2022, a notable decrease from the record-breaking 104 IPOs in 2021.
To review the highs and lows of 2023 and explore what lies ahead in 2024, distinguished biotech analyst and co-founder of Endpoints News John Carroll joins Hercules Capital's Janice Bourque. Carroll brings 45 years of award-winning journalism, and a specialization in biopharma spanning over two decades to discuss the biggest pharma deals and surprises of 2023, the impact of AI on drug development, the future of biotech in Asia, and much more.
Topics Include:

The biggest pharma deals and surprises of 2023
AI’s impact on drug development
Whether or not the Inflation Reduction Act will impact pricing
John’s major lessons from 2023
The future of biotech in Asia
The greatest concerns for the biotech industry going into 2024
John’s hopes for the industry in the new year
And other topics…

------------------
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 15 years. Carroll has been quoted by The New York Times, The New Yorker, Financial Times, The Times of London and more. He’s also keynoted at biotech gatherings around the world and addressed student audiences at MIT and Harvard. Carroll has contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press. He spent 6 years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times.
Resources Mentioned:
Endpoints News: https://endpts.com/
Connect with John:
LinkedIn: https://www.linkedin.com/in/john-carroll-884aa410/